Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐interleukin‐13 and Anti‐interleukin‐4 Agents Versus Placebo, Anti‐interleukin‐5 or anti‐immunoglobulin‐E Agents, for People With Asthma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436494/0/repview. Accessed 03 May 2024.
Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436494/0/repview. Accessed May 3, 2024.
Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436494/0/repview
Anti‐interleukin‐13 and Anti‐interleukin‐4 Agents Versus Placebo, Anti‐interleukin‐5 or anti‐immunoglobulin‐E Agents, for People With Asthma [Internet]. In: Cochrane Abstracts. [cited 2024 May 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436494/0/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma
ID - 436494
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436494/0/repview
DB - Evidence Central
DP - Unbound Medicine
ER -